ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

February 28, 1992

Recompetitions Of DCT Contracts Okayed

March 3, 1989

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

In Congress: NCI Apologizes For Delay In Report On Radioactive Fallout

September 18, 1998